FIFTYSEVEN

FIFTYSEVEN is an independent branding and web design studio, remote by design, founded in 2016 and led by Petar Stojakovic. It works with founders in Switzerland, the UK and the US, mostly in biotech, climate tech, deep tech and digital health: companies about to be read by people who are not their customers yet.

Clients tend to arrive at a defining moment. A funding round, a market entry, a launch, a hiring push, a step toward acquisition. That is when investors, pharma partners, clinicians and regulators look closely, and check everything.

End-to-end engagements under one creative direction: brand strategy and positioning, visual identity, pitch decks, websites built in-house, 3D visualisation and explainer films.

Selected work: DePoly, chemical recycling ($30M+ raised); Happy Ring, now Happy Sleep, later cleared by the FDA as a medical device ($75M+ raised, per company statements); 1910 Genetics, now 1910, an AI-native biotech from Boston ($40M raised, per the company's investor page); Roswell, now SemiconBio, and Koniku, both back for a second engagement; Yova, now Inyova ($28M+ raised, per CB Insights); Enzian Health, a clinic group that grew from one idea to eight clinics.

Every technology is shown exactly as far along as it is. No further, and no smaller.